• Cardlytics Inc CDLX.OQ CDLX.O is expected to show a fall in quarterly revenue when it reports results on March 12 for the period ending December 31 2024

• The Atlanta Georgia-based company is expected to report a 28.6% decrease in revenue to $63.627 million from $89.17 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.The company's guidance on November 6 2024, for the period ended December 31, was for revenue between $62.00 million and $67.00 million. (SAL basis is Total Revenue)

• ​LSEG's mean analyst estimate for Cardlytics Inc is for a loss of 18 cents per share.

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 4 "hold" and 1 "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Cardlytics Inc is $4.00​, above​ its last closing price of $2.00. ​​​

The company's guidance on November 6 2024 for the period ended December 31 was for Earnings before Interest, Taxes, Depreciation and Amortization of between 62 million and -1 million $(USD)$.

Previous quarterly performance (using preferred earnings measure in US dollars). ​

This summary was machine generated March 10 at 20:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)